Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies
NCT01849744
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
48
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor's decision to deprioritize the program.
Conditions
Non Hematologic Cancers
Metastatic Cancer
Interventions
DRUG:
VS-4718
Sponsor
Verastem, Inc.